Zobrazeno 1 - 10
of 376
pro vyhledávání: '"AJ Armstrong"'
Publikováno v:
Endangered Species Research, Vol 47, Pp 249-264 (2022)
Our understanding of the genetic connectivity of manta ray populations and the drivers that shape genetic population structure is still limited. This information is crucial to identify the spatial boundaries of discrete populations and guide decision
Externí odkaz:
https://doaj.org/article/594e550642d34cf18f8bfc185e1a237b
Autor:
Bryce AH; Department of Medical Oncology and Therapeutics Research, City of Hope Phoenix, Phoenix, Arizona, USA., Agarwal N; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Beltran H; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Hussain MH; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Evanston, Illinois, USA., Sartor O; Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., Shore N; Carolina Urologic Research Center, Myrtle Beach, South Carolina, USA., Antonarakis ES; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA., Armstrong AJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, North Carolina, USA., Calais J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, California, USA., Carducci MA; Hopkins Kimmel Cancer Center, Baltimore, Maryland, USA., Dorff TB; City of Hope Comprehensive Cancer Center, Duarte, California, USA., Efstathiou JA; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Gleave M; Urological Sciences, Vancouver Prostate Center, University of British Columbia, Vancouver, British Columbia, Canada., Gomella LG; Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Higano C; Madrona Oncology, Seattle, Washington, USA., Hope TA; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California, USA., Iagaru A; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California, USA., Morgans AK; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Morris DS; Urology Associates PC, Nashville, Tennessee, USA., Morris MJ; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Petrylak DP; Yale New Haven Health, New Haven, Connecticut, USA., Reiter RE; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California, USA., Rettig MB; Division of Hematology-Oncology, Department of Medicine, VA Greater Los Angeles, Los Angeles, California, USA.; Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, USA.; Department of Urology, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, USA., Ryan CJ; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Sellinger SB; Advanced Urology Institute, Tallahassee, Florida, USA., Spratt DE; University Hospitals Seidman Cancer Center, Cleveland, Ohio, USA., Srinivas S; Division of Medical Oncology, Stanford University Medical Center, Stanford, California, USA., Tagawa ST; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, New York, USA., Taplin ME; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Yu EY; Division of Hematology and Oncology, Department of Medicine, University of Washington and Fred Hutchinson Cancer Center, Seattle, Washington, USA., Zhang T; Division of Hematology and Oncology, Department of Internal Medicine, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA., McKay RR; Department of Urology, University of California San Diego, La Jolla, California, USA.; Department of Medicine, University of California San Diego, La Jolla, California, USA., Koo PJ; Banner MD Anderson Cancer Center, Phoenix, Arizona, USA., Crawford ED; Department of Urology, University of California San Diego, La Jolla, California, USA.
Publikováno v:
Cancer [Cancer] 2025 Jan 01; Vol. 131 (1), pp. e35612. Date of Electronic Publication: 2024 Dec 01.
Autor:
Rathkopf DE; Memorial Sloan Kettering Cancer Center, New York. Electronic address: rathkopd@mskcc.org., Patel MR; Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota., Choudhury AD; Dana-Farber Cancer Institute, Boston., Rasco D; START Center for Cancer Care, San Antonio., Lakhani N; START Midwest, Grand Rapids., Hawley JE; University of Washington, Fred Hutch Cancer Center, Seattle., Srinivas S; Stanford University Medical Center, Stanford., Aparicio A; UT MD Anderson Cancer Center, Houston., Narayan V; Abramson Cancer Center and Perelman School of Medicine, University of Pennsylvania, Philadelphia., Runcie KD; New York-Presbyterian/Columbia University Medical Center, New York., Emamekhoo H; Carbone Cancer Center, University of Wisconsin-Madison, Madison., Reichert ZR; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor., Nguyen MH; Bristol Myers Squibb, Princeton., Wells AL; Bristol Myers Squibb, San Francisco., Kandimalla R; Bristol Myers Squibb, Princeton., Liu C; Bristol Myers Squibb, Princeton., Suryawanshi S; Bristol Myers Squibb, Princeton., Han J; Bristol Myers Squibb, San Francisco., Wu J; Bristol Myers Squibb, Princeton., Arora VK; Bristol Myers Squibb, Princeton., Pourdehnad M; Bristol Myers Squibb, San Francisco., Armstrong AJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, USA.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2025 Jan; Vol. 36 (1), pp. 76-88. Date of Electronic Publication: 2024 Sep 16.
Autor:
Shore N; Carolina Urologic Research Center, Myrtle Beach, SC., Nielsen SM; Labcorp Genetics Inc (formerly Invitae Corp), San Francisco, CA., Esplin ED; Labcorp Genetics Inc (formerly Invitae Corp), San Francisco, CA., Antonarakis ES; University of Minnesota, Masonic Cancer Center, Minneapolis, MN., Barata PC; Case Western Reserve University, Cleveland, OH., Beer TM; The Knight Cancer Institute, Oregon Health & Science University, Portland, OR.; Exact Sciences Corporation, Madison, WI., Beltran H; Dana Faber Cancer Institute, Boston, MA., Bryce A; City of Hope Cancer Center, Goodyear, AZ., Cookson MS; Stephenson Cancer Center, OU Health, The University of Oklahoma, Oklahoma City, OK., Crawford ED; University California, San Diego, La Jolla, CA., Dorff TB; City of Hope Cancer Center, Goodyear, AZ., George DJ; Duke Cancer Institute, Duke University, Durham, NC., Heath EI; Karmanos Cancer Institute, Detroit, MI., Helfand BT; NorthShore University HealthSystem/Endeavor Health, Evanston, IL., Hussain M; Northwestern Feinberg School of Medicine, Chicago, IL., Mckay RR; University California, San Diego, La Jolla, CA., Morgans AK; Dana Faber Cancer Institute, Boston, MA., Morris MJ; Memorial Sloan Kettering Cancer Center, New York, NY., Paller CJ; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD., Ross AE; Northwestern Feinberg School of Medicine, Chicago, IL., Sartor O; Mayo Clinic, Rochester, MN., Shen J; UCLA David Geffen School of Medicine, Los Angeles, CA., Sieber P; Keystone Urology Specialists, Lancaster, PA., Smith MR; Massachusetts General Hospital, Boston, MA., Wise DR; Perlmutter Cancer Center, NYU Langone Health, New York, NY., Armstrong AJ; Duke Cancer Institute, Duke University, Durham, NC.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2024 Dec 19, pp. OP2400626. Date of Electronic Publication: 2024 Dec 19.
Autor:
Knutson TP; Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN, USA., Luo B; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA., Kobilka A; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA., Lyman J; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Graduate Program in Molecular, Cellular, and Developmental Biology and Genetics, University of Minnesota, Minneapolis, MN, USA., Guo S; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA., Munro SA; Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN, USA., Li Y; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA., Heer R; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Tyne and Wear, UK.; Translational and Clinical Research Institute, NU Cancer, Newcastle upon Tyne, Tyne and Wear, UK., Gaughan L; Translational and Clinical Research Institute, NU Cancer, Newcastle upon Tyne, Tyne and Wear, UK., Morris MJ; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Beltran H; Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Ryan CJ; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA., Antonarakis ES; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA., Armstrong AJ; Department of Medicine, Division of Medical Oncology, Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., Halabi S; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA., Dehm SM; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. dehm@umn.edu.; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA. dehm@umn.edu.; Department of Urology, University of Minnesota, Minneapolis, MN, USA. dehm@umn.edu.
Publikováno v:
Nature communications [Nat Commun] 2024 Dec 11; Vol. 15 (1), pp. 10648. Date of Electronic Publication: 2024 Dec 11.
Autor:
Barnett RM; Guardant Health, Inc, Palo Alto, California, USA., Jang A; University Hospitals Seidman Cancer Center, Cleveland, OH, USA.; Tulane Cancer Center, New Orleans, LA, USA., Lanka S; Tulane Cancer Center, New Orleans, LA, USA., Fu P; University Hospitals Seidman Cancer Center, Cleveland, OH, USA., Bucheit LA; Guardant Health, Inc, Palo Alto, California, USA., Babiker H; Mayo Clinic Jacksonville, Jacksonville, FL, USA., Bryce A; Mayo Clinic Phoenix, Phoenix, AZ, USA., Meyer HM; Mayo Clinic Phoenix, Phoenix, AZ, USA., Choi Y; Emory University, Atlanta, GA, USA., Moore C; UT Southwestern University, Dallas, TX, USA., Garje R; Miami Cancer Institute Baptist Health, Miami, FL, USA., Gao X; Massachuesetts General Hospital Cancer Center, Boston, MA, USA., Kim DW; Moffitt Cancer Institute, Tampa, FL, USA., Chang RY; University Hospitals Seidman Cancer Center, Cleveland, OH, USA., Gulhati P; Rutgers University, New Brunswick, NJ, USA., Ramaker R; Mayo Clinic, Rochester, MN, USA., Bansal R; Mayo Clinic, Rochester, MN, USA., Zhang T; UT Southwestern University, Dallas, TX, USA., Oliver Sartor A; Mayo Clinic, Rochester, MN, USA., Armstrong AJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., Bilen MA; Emory University, Atlanta, GA, USA., Barata P; University Hospitals Seidman Cancer Center, Cleveland, OH, USA. Pedro.Barata@UHhospitals.org.; Tulane Cancer Center, New Orleans, LA, USA. Pedro.Barata@UHhospitals.org.
Publikováno v:
Communications medicine [Commun Med (Lond)] 2024 Dec 02; Vol. 4 (1), pp. 256. Date of Electronic Publication: 2024 Dec 02.
Autor:
Armstrong AJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Departments of Medicine, Surgery, Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Sartor O; Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA., de Bono J; The Institute of Cancer Research and The Royal Marsden Hospital, London, UK., Chi K; Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada., Fizazi K; Cancer Medicine Department, Gustave Roussy Institute, University of Paris Saclay, Villejuif, France., Krause BJ; Department of Nuclear Medicine, Rostock University Medical Center, Rostock, Germany., Herrmann K; Clinic for Nuclear Medicine, University Hospital Essen, Essen, Germany., Rahbar K; Department of Nuclear Medicine, University Hospital Münster, Münster, Germany., Tagawa ST; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA., Saad F; Urology Department, University of Montreal Hospital Center, University of Montreal, Montreal, QC, Canada., Beer TM; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Wu J; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Mirante O; Advanced Accelerator Applications, a Novartis company, Geneva, Switzerland., Morris MJ; Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: morrism@mskcc.org.
Publikováno v:
European urology [Eur Urol] 2024 Dec; Vol. 86 (6), pp. 552-562. Date of Electronic Publication: 2024 Sep 05.
Autor:
Saad F; Centre Hospitalier de l'Université de Montréal/CRCHUM, Université de Montréal, Montreal, QC, Canada. Electronic address: fred.saad@umontreal.ca., Armstrong AJ; Duke Cancer Institute Center for Prostate and Urologic Cancer, Duke University, Durham, NC, USA., Oya M; Keio University School of Medicine, Tokyo, Japan., Vianna K; Centro Integrado de Oncologia de Curitiba, Curitiba, Brazil., Özgüroğlu M; Istanbul University Cerrahpaşa, Faculty of Medicine, Istanbul, Türkiye., Gedye C; Calvary Mater Newcastle, Waratah, NSW, Australia., Buchschacher GL Jr; Kaiser Permanente Southern California, Los Angeles, CA, USA., Lee JY; The Catholic University of Korea Seoul St Mary's Hospital, Seoul, South Korea., Emmenegger U; Sunnybrook Research Institute, Toronto, ON, Canada., Navratil J; Masaryk Memorial Cancer Institute, Brno, Czech Republic., Virizuela JA; Hospital Universitario Virgen Macarena, Sevilla, Spain., Salazar A; Instituto de Especialidades Urologicas, Santiago, Chile., Maillet D; Centre Hospitalier Lyon Sud, Pierre-Bénite, France; Faculté de Médecine Jacques Lisfranc, Saint-Etienne, France., Uemura H; Yokohama City University Medical Center, Kanagawa, Japan., Kim J; Merck & Co., Inc., Rahway, NJ, USA., Oscroft E; AstraZeneca, Cambridge, UK., Barker L; AstraZeneca, Cambridge, UK., Degboe A; AstraZeneca, Baltimore, MD, USA., Clarke NW; The Christie and Salford Royal Hospital NHS Foundation Trusts, and University of Manchester, Manchester, UK.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2024 Dec; Vol. 7 (6), pp. 1394-1402. Date of Electronic Publication: 2024 Apr 06.
Autor:
Deek MP; Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA., Sutera P; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Jing Y; The James Buchanan Brady Urological Institute of Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Gao R; Department of Radiation Oncology, The Mayo Clinic, Rochester, MN, USA., Rothman E; Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA, USA., Day H; Department of Radiation Oncology, Australian Prostate Cancer Research Center, Queensland, Australia., Chang D; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Victoria, Australia., Dirix P; Department of Radiation-Oncology, GasthuisZusters Antwerp (GZA) 'Sisters of the Hospital', Antwerp, Belgium., Armstrong AJ; Department of Medicine, Division of Medical Oncology, Duke Cancer Institute Center for Prostate and Urologic Cancer, Duke University Medical Center, Durham, NC, USA., Campbell B; Urology Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia., Lopez Campos F; Department of Radiation Oncology, Hospital Ramón y Cajal, Madrid, Spain., Berenguer M; Radiation Oncology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Ramotar M; Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Conde-Moreno A; Radiation Oncology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Berlin A; Radiation Oncology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Bosetti DG; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland., Corcoran N; Urology Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia., Koontz B; GenesisCare US, Fort Myers, FL, USA., Mercier C; Department of Radiation-Oncology, GasthuisZusters Antwerp (GZA) 'Sisters of the Hospital', Antwerp, Belgium., Siva S; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Victoria, Australia., Pryor D; Department of Radiation Oncology, Australian Prostate Cancer Research Center, Queensland, Australia., Ost P; Department of Human Structure and Repair, Ghent University, Ghent, Belgium., Huynh MA; Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA, USA., Kroeze S; Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland., Stish B; Department of Radiation Oncology, The Mayo Clinic, Rochester, MN, USA., Kiess A; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Trock B; The James Buchanan Brady Urological Institute of Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Tran PT; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA., Gillessen S; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland., Sweeney C; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia. Electronic address: christopher.sweeney@adelaide.edu.au.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2024 Dec; Vol. 7 (6), pp. 1403-1410. Date of Electronic Publication: 2024 Apr 03.
Autor:
Stenzl A; Department of Urology, University of Tübingen, Tübingen, Germany., Armstrong AJ; Division of Medical Oncology, Department of Medicine, Duke Cancer Institute Center for Prostate and Urologic Cancer, Durham, North Carolina., Rogers E; Department of Urology, University College Hospital, Galway, Ireland., Habr D; Pfizer Oncology, Pfizer Inc, New York, New York., Walz J; Department of Urology, Institut Paoli-Calmettes Cancer Center, Marseilles, France., Gleave M; Department of Urologic Sciences, The Vancouver Prostate Centre, The University of British Columbia, Vancouver, British Columbia, Canada., Sboner A; Department of Pathology and Laboratory Medicine, Institute for Computational Biomedicine, Meyer Cancer Center, Weill Cornell Medicine, New York, New York., Ghith J; Pfizer Oncology, Pfizer Inc, New York, New York., Serfass L; Pfizer Oncology, Pfizer Inc, Paris, France., Schuler KW; Pfizer Oncology, Pfizer Inc, New York, New York., Garas S; Pfizer Oncology, Pfizer Inc, New York, New York., Chari D; Pfizer Oncology, Pfizer Inc, New York, New York., Truman K; Insights & Connections, MedThink Inc, Cary, North Carolina., Sternberg CN; Englander Institute for Precision Medicine, Meyer Cancer Center, Weill Cornell Medicine, New York Presbyterian Center, New York, New York.
Publikováno v:
Urology practice [Urol Pract] 2024 Nov 07, pp. 101097UPJ0000000000000740. Date of Electronic Publication: 2024 Nov 07.